Skip to search formSkip to main contentSkip to account menu

abatacept 250 MG Injection [Orencia]

Known as: Orencia 250 MG Injection, abatacept 250 mg in 15 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ORENCIA] 
National Institutes of Health

Related topics

Related topics

6 relations
InjectionOrenciaSodium ChlorideSodium Phosphate, Monobasic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
CHMP Issues Positive Opinion for ORENCIA ® ( abatacept ) in the Treatment of Highly Active and Progressive Disease in Adult Patients with Rheumatoid Arthritis not Previously Treated with Methotrexate…
  • 2019
  • Corpus ID: 156054248
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that the Committee for Medicinal… 
2018
2018
High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis
BackgroundResponse prediction of certain biologic agents for the treatment of rheumatoid arthritis (RA) remains an unmet need in… 
Review
2018
Review
2018
Ankylosing Spondylitis as Etiologic Factor in Condylar Resorption: Comprehensive Review and Case Report
Ankylosing spondylitis is an autoimmune chronic inflammatory disorder that produces different degree of fibrosis and ossification… 
2018
2018
Abatacept in active psoriatic arthritis: a profile of its use
The biological DMARD abatacept (Orencia®), a selective co-stimulation modulator, is an effective and generally well tolerated… 
Review
2017
Review
2017
An Oral Physicians Perspective of the Usage of Biologics in Pregnancy, Lactation and Pediatrics
Biologics are newer drugs in the arsenal of therapeutics. These are agents which counteract the natural inflammatory process of… 
2015
2015
Vesikulobullöses Granuloma anulare unter Etanercept- bzw. Abatacept-Therapie
Zusammenfassung Wir berichten über eine 77-jährige Patientin mit schwerer, therapierefraktärer rheumatoider Arthritis, die… 
2014
2014
Interference of therapeutic monoclonal immunoglobulins in the investigation of M-proteins
2013
2013
Patients with rheumatoid arthritis who have failed everything else may respond to abatacept
National Institute for Health and Clinical Excellence (NICE) have decided that abatacept (ORENCIA®, BristolMyers Squibb) is not… 
2012
2012
Éruption paradoxale psoriasiforme induite par l’abatacept (ORENCIA®)
2012
2012
[Paradoxical psoriasiform eruption due to abatacept (ORENCIA(®))].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)